Your session is about to expire
← Back to Search
Bevacizumab for Brain Cancer
Study Summary
This trial is testing if repeated doses of the drug bevacizumab, given through a catheter directly to the brain, are safe and effective in treating patients with recurrent brain tumors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 45 Patients • NCT02036424Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a confirmed diagnosis of a specific type of brain tumor that has returned or is not responding to treatment.I have received more than 2 cycles of Bevacizumab at 10mg/kg.I am mostly independent and can care for myself.I am 18 years old or older.I have at least one tumor confirmed by biopsy.I am not pregnant or breastfeeding.
- Group 1: Arm 2
- Group 2: Arm 1
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open slots remaining for this clinical trial?
"That is correct. The listing on clinicaltrials.gov affirms that this study, which was first posted on 10/1/2010, is looking for new participants. A total of 54 patients will be enrolled at 1 site."
How many individuals are being given this medication as part of the research?
"That is correct. The trial, which was first advertised on October 1st 2010 and has since been edited November 10th 2022, is still looking for patients. A total of 54 people are needed at a single site."
What has Bevacizumab been traditionally used to alleviate?
"Bevacizumab is a medication used to treat cancer. More specifically, it has been shown to be effective in treating recurrent platinum sensitive primary peritoneal cancer, stage iv epithelial ovarian cancer following initial surgical resection, and locally advanced nonsquamous non-small cell lung cancer."
What other investigational uses has Bevacizumab been trialed for?
"Currently, 375 clinical trials are underway to test the efficacy of bevacizumab. Of these, 99 are in Phase 3. Many of the bevacizumab trials are based in Taibei, Taiwan; however, there are a total of 18908 locations running studies for this treatment across the globe."
Share this study with friends
Copy Link
Messenger